 |
市場調查報告書
商品編碼
1190254
細胞培養基袋市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)Cell Culture Media Bags Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計在預測期內（2022 年至 2027 年），細胞培養基袋市場的複合年增長率為 10%。
由於疫苗接種需求增加，預計 COVID-19 的爆發將對細胞培養基袋市場產生重大影響。 細胞培養基袋在疫苗接種和蛋白質藥物生產中發揮著重要作用。 細胞培養基袋在候選疫苗的研發和測試過程中被廣泛使用。 根據《計算與結構生物技術雜誌》2021 年發表的一篇論文，有 184 種候選疫苗處於臨床前試驗階段，88 種其他候選疫苗處於臨床階段。 因此，COVID-19 大流行對細胞培養袋市場產生了積極影響，並促進了其增長。
生物製藥領域研發活動的增加預計將推動市場增長。 根據印度品牌資產基金會的數據，印度在 2020 年擁有超過 2,700 家生物技術初創公司，預計到 2024 年將達到 10,000 家。 Seed Scientific 還宣布，到 2021 年，將有超過 6,600 家生物技術公司活躍在美國的研發活動中。 細胞培養基袋通過提供生物製藥開發所需的適當營養物質來促進靶細胞生長。 此類細胞培養袋的顯著優勢增加了生物製藥對細胞培養基的擴增、儲存和濃縮的需求。 因此，對生物製藥不斷增長的需求正在推動細胞培養袋市場的增長。 它還廣泛用於乾細胞和腫瘤學研究，因為它提供了支持靶細胞生命週期的人工環境。 全球人口中癌症患病率的上升以及對開創性治療的需求不斷增加預計將推動市場增長。 根據全球癌症觀察站的數據，2021 年全球將有約 120 萬年輕人被診斷出患有癌症。 越來越多的癌症患者需要有效的治療方案，並增加了對細胞培養液袋的需求，因為它們在癌細胞研究中被廣泛採用。 這是因為細胞培養袋的設計目的是將採購的細胞分開，並通過防止暴露於外部環境來完成氣密密封，從而可以研究癌細胞的行為和腫瘤細胞的生長情況，有助於設計治療方法。
人口老齡化等因素更容易患上慢性病和疾病，這推動了對生物製藥的需求，導致製造商越來越多地使用細胞培養基袋。 根據美國疾病控制和預防中心 (CDC) 的數據，到 2020 年，大約 85% 的老年人將患有至少一種慢性疾病，而 60% 的老年人將患有至少兩種。。 因此，老年人口的增加以及對生物製藥需求的增加預計將推動市場的增長。
細胞培養中袋市場趨勢
2D 細分市場有望主導市場份額
COVID-19 的突然爆發增加了對用於治療和接種感染者的生物製藥的需求。 此外，二維設計中袋預計在預測期內將佔據很大份額，例如用於新藥開發和使用細胞的研究。
由於細胞培養基袋越來越多地用於生物製藥行業的產品開發，因此二維設計的細胞培養基袋有望佔據主要市場份額。 需求的增加是由於全球抗擊癌症等新興疾病的研發活動增加。 介質袋還可以通過減少滅菌和清潔步驟來降低生產成本。 其他優點包括重量輕、高阻隔和減少污染情況，二維設計的細胞培養袋適用於生物製藥行業。
此外，生物製藥行業在新療法研發方面的支出增加等主要因素預計將對市場增長產生重大影響。 根據經濟合作與發展組織（OECD）2020年公佈的數據，OECD國家製藥行業在研發方面的支出約為1010億美元。 同一消息來源還報導說，全球最大的上市公司的研發支出每年增長 13.7%。 因此，生物製藥行業增加研發支出以開發其產品線有望推動市場研究領域的增長。 因此，細胞培養基袋的二維設計有望佔據主要市場份額。
預計北美將佔據很大的市場份額，預計在預測期內也是如此。
在美國地區，不斷專注於開發新的先進療法的製藥和生物技術行業的繁榮是市場增長的主要因素之一。 根據美國研究組織的數據，2020 年美國用於開發新療法的醫療衛生研發達到 2541 億美元，佔總支出的 67%。 市場增長也受到該地區早期採用基因表達和疫苗等技術進步的推動。 此外，尋求有效治療的人群中越來越多的慢性病患者增加了該地區對細胞培養基袋的需求。 例如，正如美國疾病控制與預防中心 (CDC) 在 2021 年宣布的那樣，每 10 個美國人中就有 6 個患有至少一種慢性疾病，例如心髒病或癌症。 因此，對新型療法的需求不斷增加，導致細胞培養基袋的使用量增加，從而推動了該地區的市場增長。 此外，該地區主要市場參與者的存在也是該地區市場增長的主要因素。
細胞培養基袋市場競爭分析
細胞培養基袋市場是分散的，由幾家主要參與者組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 目前主導市場的公司包括 Thermo Fisher Scientific、Sartorius AG、Corning Incorporated、Danaher、Fukoku、OriGen Biomedical、Lonza、Saint-Gobain Performance Plastics、Shanghai LePure Biotech、Technoflex 等。
其他福利。
- Excel 格式的市場預測 (ME) 表
- 3 個月的分析師支持
內容
第一章介紹
- 研究假設和市場定義
- 調查範圍
第二章研究方法論
第 3 章執行摘要
第四章市場動態
- 市場概覽
- 市場驅動因素
- 提高生物製藥、腫瘤學和乾細胞研究的增長潛力
- 老年人口增加
- 市場製約因素
- 污染和廢物處理的可能性增加
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分
- 設計
- 二維
- 3D
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東和非洲
- 海灣合作委員會
- 南非
- 其他中東和非洲地區
- 南美洲地區
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章競爭格局
- 公司簡介
- Thermo Fischer Scientific
- Sartorius AG
- Corning Incorporated
- Danaher
- Fukoku Co. Ltd
- OriGen Biomedical
- Lonza
- Saint-Gobain Performance Plastics
- Shanghai LePure Biotech Co. Ltd
- Technoflex
第7章 市場機會今後動向
The cell culture media bags market is projected to register a CAGR of 10% during the forecast period (2022-2027).
The COVID-19 outbreak is expected to have a significant impact on the cell culture media bags market due to the increasing demand for vaccination. The cell culture media bags play a crucial role in the production of vaccination and protein-based drug. The cell culture media bags are extensively used in the developmental phases and trial process of vaccine candidates. According to the article published by the Computational and Structural Biotechnology Journal in 2021, there are 184 vaccine candidates in pre-clinical testing and other 88 vaccine candidates in clinical phases. Thus, the COVID-19 pandemic has impacted the cell culture media bags market positively and contributed to its growth.
The increasing R&D activities in the biopharmaceutical sectors are expected to drive the growth of the market. According to the India Brand Equity Foundation, in 2020, there were more than 2700 biotech startups in India, which is estimated to reach 10,000 by 2024. Also, Seed Scientific Published in 2021 that over 6,600 biotech companies operate in United States with active research and development activities. Cell culture media bags allow the growth of the target cells by providing suitable nutrients required for the development of biopharmaceuticals. This remarkable advantage of cell culture bags increased their demand in biopharmaceuticals for the expansion, storage, and concentration of cell culture mediums. Thus, the rising demand for biopharmaceuticals drives the growth of the cell culture media bags market. They are also extensively used in stem cell research and oncological studies as they provide an artificial environment that aids the life cycle of the target cells. The rising prevalence of cancer among the global population and the increasing necessity for the development of treatment are expected to drive the growth of the market. According to the Global Cancer Observatory, in 2021, around 1.2 million young adults were diagnosed with cancer across the world. Such increasing cancer cases demand effective treatment therapies, which increases the demand for cell culture media bags as they are widely employed in the study of cancer cells. This is due to cell culture bags being designed to isolate the procured cells and complete sealing by preventing exposure to the outside environment, which helps study the behavior of cancer cells and design a treatment for tumor cells.
Factors like the increasing geriatric population that is prone to chronic conditions and diseases drive the demand for biopharmaceuticals, resulting in the increasing usage of cell culture media bags by manufacturers. According to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 85% of older adults had at least one chronic health condition, and 60% had at least two chronic conditions. Therefore, the increasing geriatric population, coupled with the rising demand for biopharmaceuticals, is expected to drive the growth of the market.
Cell Culture Media Bags Market Trends
The 2D Segment is Expected to Hold a Major Market Share
The sudden outbreak of COVID-19 had increased the demand for biologics to treat the infected people and provide vaccinations. The 2D design of the cell culture media bags segment is expected to hold the major share in the forecast period owing to the novel drug development and cell-based studies.
2D design cell culture media bags are expected to hold the major share in the market due to the increasing usage of cell culture media bags in the biopharmaceutical industries for their product development. The increasing demand is due to the increase in research and development activities to conquer emerging diseases, such as cancer, across the world. Also, cell culture media bags reduce the cost of production by decreasing the sterilization and cleaning processes. Additionally, the benefits offered by 2D design cell culture bags such as lightweight, high barrier, and decreased contamination cases make them more suitable for the biopharmaceutical industry.
Also, key factors such as increasing expenditure in the research and development by biopharmaceutical industries to novel treatments are expected to have a significant impact on the growth of the market. According to data published by the Organisation for Economic Co-Operation and Development (OECD) in 2020, the pharmaceutical industry spent nearly USD 101 billion on research and development in the OECD countries. Also, from the same source, it is reported that global R&D spending by the largest publicly- traded companies grew by 13.7% annually. Therefore, the increasing expenditure on research and development by the biopharmaceutical industry to develop their product pipelines is expected to boost the growth of the studied segment in the market. Hence, the 2D design of cell culture media bags is expected to hold the major market share.
North America is Expected to Hold a Significant Share in the Market, and It is Expected to do the Same During the Forecast Period
The flourishing presence of pharmaceutical and biotechnology industries, which are constantly focusing on the development of new and advanced therapies in the US region, is one of the major factors for the market growth. According to the Research America Organization in 2020, US medical and health R&D reached USD 254.1 billion for the development of novel treatments, which is 67% of the total spending. Also, the quick adoption of technological advancements in gene expression, vaccines, etc., in this region is also a contributing factor to the growth of the market. Also, factors such as the rising prevalence of chronic disorders among people demanding effective therapies and treatments also increased the demand for cell culture media bags in this region. For instance, six in ten Americans live with at least one chronic condition such as heart disease, cancer, etc., as published by the Centers for Disease Control and Prevention (CDC) in 2021. Thus, the increase in demand for novel treatment therapies, contributing to the increasing usage of cell culture media bags, is driving the growth of the market in this region. Additionally, the presence of major market players in this region is also a major factor in the growth of the market in this region.
Cell Culture Media Bags Market Competitive Analysis
The cell culture media bags market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies currently dominating the market are Thermo Fisher Scientific, Sartorius AG, Corning Incorporated, Danaher, Fukoku Co. Ltd, OriGen Biomedical, Lonza, Saint Gobain Performance Plastics, Shanghai LePure Biotech Co. Ltd, Technoflex, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Growth in Biopharmaceuticals, Oncology, and Stem Cell Research
- 4.2.2 Increasing Geriatric Population
- 4.3 Market Restraints
- 4.3.1 Increased Possibility of Contamination and Waste Disposal
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
- 5.1 Design
- 5.1.1 2D
- 5.1.2 3D
- 5.2 Geography
- 5.2.1 North America
- 5.2.1.1 United States
- 5.2.1.2 Canada
- 5.2.1.3 Mexico
- 5.2.2 Europe
- 5.2.2.1 Germany
- 5.2.2.2 United Kingdom
- 5.2.2.3 France
- 5.2.2.4 Italy
- 5.2.2.5 Spain
- 5.2.2.6 Rest of Europe
- 5.2.3 Asia-Pacific
- 5.2.3.1 China
- 5.2.3.2 Japan
- 5.2.3.3 India
- 5.2.3.4 Australia
- 5.2.3.5 South Korea
- 5.2.3.6 Rest of Asia-Pacific
- 5.2.4 Middle-East and Africa
- 5.2.4.1 GCC
- 5.2.4.2 South Africa
- 5.2.4.3 Rest of Middle-East and Africa
- 5.2.5 South America
- 5.2.5.1 Brazil
- 5.2.5.2 Argentina
- 5.2.5.3 Rest of South America
- 5.2.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Thermo Fischer Scientific
- 6.1.2 Sartorius AG
- 6.1.3 Corning Incorporated
- 6.1.4 Danaher
- 6.1.5 Fukoku Co. Ltd
- 6.1.6 OriGen Biomedical
- 6.1.7 Lonza
- 6.1.8 Saint- Gobain Performance Plastics
- 6.1.9 Shanghai LePure Biotech Co. Ltd
- 6.1.10 Technoflex
